Kaya Holdings (KAYS) Accumulated Expenses (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Accumulated Expenses of $40384.0 in Q3 2025, little changed quarter-over-quarter from $40216.0 in Q2 2025, and down 98.48% on a YoY basis from $2.7 million in Q3 2024.
Kaya Holdings (KAYS) Accumulated Expenses (2011 - 2025) Analysis & Trends
Kaya Holdings' Accumulated Expenses history runs 15 years deep, the most recent figure standing at $40384.0 for Q3 2025.
- In Q3 2025, Accumulated Expenses fell 98.48% year-over-year to $40384.0; the TTM figure through Sep 2025 stood at $40384.0 (down 98.48% YoY), while the FY2024 annual figure was $3.0 million, up 26.85% from the prior year.
- Accumulated Expenses was $40384.0 for Q3 2025 at Kaya Holdings, roughly flat from $40216.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $3.2 million in Q1 2025 to a low of $2193.0 in Q3 2023.
- Historically, Accumulated Expenses has averaged $1.4 million across 5 years, with a median of $1.3 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses tumbled 99.86% in 2023, then surged 121183.72% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $1.2 million in 2021, then slumped by 94.66% to $61573.0 in 2022, then soared by 3747.49% to $2.4 million in 2023, then climbed by 26.85% to $3.0 million in 2024, then sank by 98.66% to $40384.0 in 2025.
- The last three Accumulated Expenses figures came in at $40384.0 (Q3 2025), $40216.0 (Q2 2025), and $3.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 40,384.00 |
| Jun 30, 2025 | 40,216.00 |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 29,964.00 |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2,193.00 |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 61,573.00 |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 856,633.00 |
| Mar 31, 2021 | 741,710.00 |
| Dec 31, 2020 | 616,329.00 |